CELU Stock Analysis: Buy, Sell, or Hold?
CELU - Celularity Inc. Class A Common Stock
$2.10
1.22 (138.53%)
▲
5d:
+173.79%
30d:
+213.39%
90d:
+111.91%
WAIT
LOW Confidence
Analysis Updated: Aug 27, 2026 12:00 AM ET
Earnings: Sep 04, 2026
6d
Get Alerted When CELU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CELU is 101.9% above its trading range ($1.04). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CELU is 101.9% above its trading range ($1.04). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CELU is currently trading at $2.10, which is considered extended relative to its 30-day fair value range of $0.53 to $1.04.
Technical Outlook: Technically, CELU is in a downtrend. Immediate support is located at $0.68, while resistance sits at $2.55. The stock is showing strong short-term momentum, up 138.5% recently.
Market Sentiment: CELU scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.50 (+19.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CELU is in a downtrend. Immediate support is located at $0.68, while resistance sits at $2.55. The stock is showing strong short-term momentum, up 138.5% recently.
Market Sentiment: CELU scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.50 (+19.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.53 -
$1.04
Company Quality Score
31/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
13.2%
Protect Your Profits
CELU is technically overbought (RSI 93). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+101.9% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: Strong upward momentum (+138.5%)
- BULLISH: Trading below Wall St target ($2.50)
- WARNING: Pump-risk flag — this pattern historically reverses hard
Trading Range Analysis
30-Day Trading Range
$0.53 -
$1.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.68
Resistance Level
$2.55
Current Trend
Downtrend
Technical data as of
Aug 27, 2026
Fundamental Context
Wall Street Target
$2.50
(+19.0%)
Revenue Growth (YoY)
-77.4%
Earnings Growth (YoY)
-61.3%
Share & Embed Analysis
Last updated: August 27, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 49 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 35 SELL |
Advanced CELU Option Strategies
Professional options setups generated by AI based on today's CELU price and gamma walls.
